[1]
Chen, W. et al. 2022. COMPARISON OF CARDIOVASCULAR EVENTS AMONG USERS OF DIFFERENT CLASSES OF ANTI-OSTEOPOROSIS MEDICATIONS. Journal of the ASEAN Federation of Endocrine Societies. 37, 2 (Oct. 2022), 27. DOI:https://doi.org/10.15605/jafes.037.AFES.35.